Efficacy of lateral lymph node dissection for local control of rectal cancer: A multicenter study

被引:0
|
作者
Tanaka, Yusuke [1 ]
Hino, Hitoshi [1 ,9 ]
Shiomi, Akio [1 ]
Uehara, Kay [2 ]
Watanabe, Jun [3 ]
Nishikawa, Takeshi [4 ]
Ueno, Hideki [5 ]
Kinugasa, Yusuke [6 ]
Kawai, Kazushige [7 ]
Ajioka, Yoichi [8 ]
机构
[1] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, Shizuoka, Japan
[2] Nippon Med Sch, Div Gastrointestinal & Hepatobiliary Pancreat Surg, Tokyo, Japan
[3] Yokohama City Univ, Gastroenterol Ctr, Med Ctr, Dept Surg, Yokohama, Japan
[4] Saitama Canc Ctr, Div Gastroenterol Surg, Ina, Japan
[5] Natl Def Med Coll, Dept Surg, Tokorozawa, Japan
[6] Tokyo Med & Dent Univ, Dept Gastrointestinal Surg, Tokyo, Japan
[7] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Dept Colorectal Surg, Tokyo, Japan
[8] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Diagnost Pathol, Niigata, Japan
[9] Shizuoka Canc Ctr Hosp, Div Colon & Rectal Surg, 1007 Shimonagakubo,Nagaizumi Cho, Shizuoka 4118777, Japan
来源
关键词
lateral lymph node dissection; lateral lymph node metastasis; local recurrence; rectal cancer; total mesorectal excision; PREOPERATIVE CHEMORADIOTHERAPY; MESORECTAL EXCISION; METASTASIS; BENEFIT; JAPAN;
D O I
10.1002/ags3.12789
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundThis study aimed to evaluate the efficacy of lateral lymph node dissection (LLND) for rectal cancer by comparing the local control in patients with and without pathological lateral lymph node metastasis (LLNM).MethodsWe included 189 patients with rectal cancer who underwent total mesorectal excision and LLND at 13 institutions between 2017 and 2019. Patients with and without pathological LLNM were defined as the pLLNM (+) and (-) groups, respectively. Propensity score-matching helped to balance the basic characteristics of both groups. The incidences of local recurrence (LR) and lateral lymph node recurrence (LLNR) were compared between the groups.ResultsIn the entire cohort, 39 of the 189 patients had pathological LLNM. The 3-year LR and LLNR rates were 18.3% and 4.0% (p = 0.01) and 7.7% and 3.3% (p = 0.22) in the pLLNM (+) and (-) groups, respectively. After propensity score matching, the data from 62 patients were analyzed. No significant differences in LR or LLNR were observed between both groups. The 3-year LR and LLNR rates were 16.4% and 9.8% (p = 0.46) and 9.7% and 9.8% (p = 0.99) in the pLLNM (+) and (-) groups, respectively.ConclusionLLND would lead to comparable local control in the pLLNM (+) and (-) groups if the clinicopathological characteristics except for LLNM are similar. This study compared the incidence of local recurrence (LR) and lateral lymph node recurrence (LLNR) after total mesorectal excision and lateral lymph node dissection (LLND) between patients with and without pathological lateral lymph node metastasis (LLNM), using multicenter prospective data to assess the impact of LLND on the local control of rectal cancer. In the entire cohort, the 3-year LR and LLNR rates were 18.3% and 4.0% (p = 0.01) and 7.7% and 3.3% (p = 0.22) in the patients with and without pathological LLNM, while no significant differences in LR or LLNR were observed between both groups after propensity score matching. LLND would lead to comparable local control in the patients with and without pathological LLNM if the clinicopathological characteristics except for LLNM are similar.image
引用
收藏
页码:631 / 638
页数:8
相关论文
共 50 条
  • [21] Lateral lymph node dissection in rectal cancer patients: is there any indication?
    Benno Mann
    International Journal of Colorectal Disease, 2004, 19 : 195 - 196
  • [22] Transanally assisted lateral pelvic lymph node dissection for rectal cancer
    Matsuda, Takeru
    Sawada, Ryuichiro
    Hasegawa, Hiroshi
    Yamashita, Kimihiro
    Utsumi, Masako
    Harada, Hitoshi
    Urakawa, Naoki
    Goto, Hironobu
    Kanaji, Shingo
    Oshikiri, Taro
    Kakeji, Yoshihiro
    SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2023, 37 (02): : 1562 - 1568
  • [23] Lateral lymph node dissection in rectal cancer patients: is there any indication?
    Mann, B
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2004, 19 (03) : 195 - 196
  • [25] Lateral pelvic lymph node dissection for rectal cancer: unfinished business?
    Cribb, Benjamin
    Kong, Joseph
    McCormick, Jacob
    Warrier, Satish
    Heriot, Alexander
    ANZ JOURNAL OF SURGERY, 2020, 90 (7-8) : 1228 - 1229
  • [26] Venous Thromboembolism Following Lateral Lymph Node Dissection for Rectal Cancer
    Kobayashi, Yuta
    Uemura, Mamoru
    Paku, Masakatsu
    Kitakaze, Masatoshi
    Tei, Mitsuyoshi
    Kagawa, Yoshinori
    Takeda, Mitsunobu
    Sekido, Yuki
    Hata, Tsuyoshi
    Hamabe, Atsushi
    Ogino, Takayuki
    Miyoshi, Norikatsu
    Doki, Yuichiro
    Eguchi, Hidetoshi
    ANTICANCER RESEARCH, 2024, 44 (02) : 695 - 701
  • [27] Surgical navigation for lateral pelvic lymph node dissection in rectal cancer
    K. Ochiai
    S. Ishihara
    Techniques in Coloproctology, 2025, 29 (1)
  • [28] Lateral pelvic lymph node dissection for advanced lower rectal cancer
    Fujita, S
    Yamamoto, S
    Akasu, T
    Moriya, Y
    BRITISH JOURNAL OF SURGERY, 2003, 90 (12) : 1580 - 1585
  • [29] Transanally assisted lateral pelvic lymph node dissection for rectal cancer
    Takeru Matsuda
    Ryuichiro Sawada
    Hiroshi Hasegawa
    Kimihiro Yamashita
    Masako Utsumi
    Hitoshi Harada
    Naoki Urakawa
    Hironobu Goto
    Shingo Kanaji
    Taro Oshikiri
    Yoshihiro Kakeji
    Surgical Endoscopy, 2023, 37 : 1562 - 1568
  • [30] The role of lateral lymph node dissection in the management of lower rectal cancer
    Ziting Wang
    Kep Yong Loh
    Kok-Yang Tan
    Emile Chung-Hou Woo
    Langenbeck's Archives of Surgery, 2012, 397 : 353 - 361